Biosenic SA (BIOS)

Currency in EUR
0.0024
0.0000(0.00%)
Closed·
BIOS Scorecard
Full Analysis
Quickly burning through cash
BIOS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.00230.0025
52 wk Range
0.00120.0160
Key Statistics
Prev. Close
0.01
Open
0.0024
Day's Range
0.0023-0.0025
52 wk Range
0.0012-0.016
Volume
622.43K
Average Volume (3m)
5.22M
1-Year Change
-72.73%
Book Value / Share
-0.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Neutral
Moving Averages
Strong Buy

Biosenic SA Company Profile

BioSenic S.A., a biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France. The company’s technologies include arsenic trioxide (ATO) and oral arsenic trioxide (OATO) platforms. It also provides medicinal products, including ArsciMed, an intravenous drug to treat autoimmune diseases. In addition, the company develops ArsciCor, an oral medication in Phase III clinical trial and for the treatment for chronic graft-versus-host disease; JTA-004, an intra-articular injectable in Phase III clinical trial to treat osteoarthritic knee pain; ALLOB, an allogeneic differentiated osteoblast product in Phase IIb clinical trial for patients with difficult tibial fractures and lumbar spinal fusion; and ARSCICOP, an oral medication in Phase IIa trial for the treatment of systemic lupus erythematosus, as well as in preclinical trial to treat systemic sclerosis. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.

Employees
2
Market
Belgium

Compare BIOS to Peers and Sector

Metrics to compare
BIOS
Peers
Sector
Relationship
P/E Ratio
−0.2x−3.5x−0.5x
PEG Ratio
0.00−0.030.00
Price/Book
−0.1x1.6x2.6x
Price / LTM Sales
0.6x19.0x3.3x
Upside (Analyst Target)
-110.7%43.5%
Fair Value Upside
Unlock−1.3%6.9%Unlock

Earnings

Latest Release
Sep 29, 2024
EPS / Forecast
-- / --
Revenue / Forecast
2.69M / --
EPS Revisions
Last 90 days

BIOS Income Statement

People Also Watch

13.89
BAR
+2.06%
213.10
PRTP
+1.84%
0.0656
NYR
-5.48%
0.750
BELYS
-1.96%
37.20
BEKB
+1.78%

FAQ

What Stock Exchange Does Biosenic Trade On?

Biosenic is listed and trades on the Brussels Stock Exchange stock exchange.

What Is the Stock Symbol for Biosenic?

The stock symbol for Biosenic is "BIOS."

What Is the Biosenic Market Cap?

As of today, Biosenic market cap is 1.57M.

What Is Biosenic's Earnings Per Share (TTM)?

The Biosenic EPS (TTM) is -0.04.

From a Technical Analysis Perspective, Is BIOS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Biosenic Stock Split?

Biosenic has split 0 times.

How Many Employees Does Biosenic Have?

Biosenic has 2 employees.

What is the current trading status of Biosenic (BIOS)?

As of 07 Aug 2025, Biosenic (BIOS) is trading at a price of 0.00, with a previous close of 0.01. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.02.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.